Identity
PassHPLC-UV/VIS match to reference standard
COMPOUND IQRESEARCH. TESTED. EXPLAINED.Scan your COADOCUMENT REVIEW · AUGUST 2026
Core Peptides AOD-9604: a current COA with a narrow testing scope.
We reviewed Vanguard Laboratory report V260706-2 for AOD-9604 5 mg, lot C74106, reported July 22, 2026.
Compound IQ has no affiliate relationship with Core Peptides. We did not purchase or independently test this lot. This score reviews the public certificate—not the company’s entire catalog or supplier quality.
WHAT THE CERTIFICATE REPORTS
3 of 7 evidence categories documented.
The one-page Vanguard Laboratory certificate reports an HPLC reference-standard identity match and 99.08% chromatographic purity for the submitted sample. Reference: V260706-2 · LOT C74106.
Purity
99.08%HPLC-UV/VIS · reported uncertainty ±0.18%Measured quantity
Not reportedThe 5 mg entry is a stated quantity, not a measured-content resultLot traceability
C74106Lot appears on the certificate and supplier pageSterility
Not reportedNo sterility or microbial result on this certificateEndotoxin
Not reportedNo quantitative endotoxin result or methodContaminants
Not reportedNo heavy-metal, solvent, or other contaminant panelA chromatographic purity percentage describes peaks detected under this method. It does not substitute for measured vial content or the missing test categories.
WHAT THE HEADLINE DOES NOT SAY
Four limits that belong beside the score.
The 5 mg line is not an assay result
The certificate states “Quantity: 5 mg,” but it does not report a measured net-content or potency result. We treat that entry as a sample description rather than proof of vial quantity.
Only two analytical questions are answered
The report covers identity by HPLC comparison and chromatographic purity. It does not report sterility, endotoxin, heavy metals, residual solvents, or another contaminant screen.
The lab did not select the sample
Vanguard states that it did not observe or participate in sample selection and cannot confirm that the submitted sample represents the associated lot or batch.
One report does not cover future inventory
This certificate is specific to the submitted portion of lot C74106. It should not be generalized to another Core Peptides lot or product.
COMPOUND IQ VERDICT
Useful identity and purity evidence. Incomplete quality coverage.
This is a recent, lot-identified third-party report with clear methods and a named laboratory. It is still a narrow certificate. The missing measured-content, sterility, endotoxin, and contaminant results should remain visible whenever the 99.08% headline is discussed.
SOURCE DOCUMENTS
Inspect the evidence directly.
Read the original certificate, match any current vial to its exact lot, and do not extend this result to another batch or product.